Brasília – Seven months after the Federal Council of Medicine (CFM) established a rule requiring physicians to disclose relationships with the pharmaceutical and medical device industries, only 30 professionals have filed declarations nationwide, according to UOL. The measure, introduced through Resolution 2.386/2024, aims to bring more transparency to financial ties between doctors and private companies.

The low compliance rate — equivalent to just 0.005% of Brazil’s more than 600,000 registered physicians — exposes the challenges in implementing the regulation. The CFM has not yet published the submitted declarations nor launched a monitoring mechanism to ensure adherence.

The rule covers sponsorships, research funding, consulting fees, and any form of payment or partnership involving doctors and healthcare companies. Experts say the lack of enforcement risks perpetuating opaque practices and weakens public trust in medical independence, especially in prescription and procurement decisions within the public health system.

Source: UOL

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com